ARCH ADEPTT

The ARCH ADEPTT trial studies tuberculosis preventative therapy (IPT) in HIV+ adults in Uganda who drink heavily. The study is meant to evaluate the risks and benefits of IPT within this population. A simulation model component will use results from the trial to simulate out effects at a population level.